An Effectiveness Study of Paromomycin IM Injection (PMIM) for the Treatment of Visceral Leishmaniasis (VL) in Bangladesh
Status:
Completed
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effectiveness of treatment with PMIM in patients
with visceral leishmaniasis within the VL-endemic region of Bangladesh at EOT (21/22 days
after treatment begins), and at 6 months after end of treatment (Day 202/203, -15 to +30
days).
Phase:
N/A
Details
Lead Sponsor:
PATH
Collaborators:
GVK Biosciences GVK Biosciences Private Limited, Gurgaon, India International Centre for Diarrhoeal Disease Research, Bangladesh Shaheed Suhrawardy Medical College Hospital, Dhaka, Bangladesh